Novel chemogenetic approaches in modulating calcium signaling
Biochemical Society Transactions · 2026
DOI: 10.1042/bst20250509 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemical Society Transactions, 2026. Verfasst von Anna Price und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Cancer Research, Institute of Biosciences and Technology, College of Medicine, Texas A&M University, Houston, TX 77030, U.S.…. Hauptthemen laut MEDLINE: Calcium Signaling, Calcium. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Prevention and Research Institute of Texas (CPRIT), HHS | NIH | National Institute of General Medical Sciences (NIGMS), NIGMS NIH HHS.
Abstract (Originalsprache)
Calcium (Ca2+) signals regulate diverse processes ranging from neurotransmission and muscle contraction to gene expression, immune response, and cell death. Conventional pharmacological agents are readily applied but often lack molecular and cell-type specificity, whereas genetic perturbations offer greater precision but are typically slow and difficult to reverse. Chemogenetic systems bridge these approaches by combining genetically encoded protein actuators with exogenous chemical ligands. The present review summarizes emerging chemogenetic strategies that modulate Ca2+ signaling at distinct steps of the signaling cascade. These include engineered G protein-coupled receptors, chemically inducible receptor tyrosine kinases, direct actuators and inhibitors of STIM–ORAI coupling, genetically encoded blockers of voltage-gated Ca2+ channels, and engineered ligand-gated ion channels. We also discuss prospective designs targeting the phospholipase C signaling axis. Collectively, these approaches enable reversible and cell-specific modulation of Ca2+ dynamics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Translational Cancer Research, Institute of Biosciences and Technology, College of Medicine, Texas A&M University, Houston, TX 77030, U.S.A.
- Department of Translational Medical Sciences, College of Medicine, Texas A&M University, TX 77030, U.S.A.
ORCID-Profile: Tien-Hung Lan, Yubin Zhou
Förderung
- Cancer Prevention and Research Institute of Texas (CPRIT)
- HHS | NIH | National Institute of General Medical Sciences (NIGMS)
- NIGMS NIH HHS
- Welch Foundation (The Welch Foundation)
Zitieren
APA
Price, A., Lan, T. H., & Zhou, Y. (2026). Novel chemogenetic approaches in modulating calcium signaling. Biochemical Society Transactions. https://doi.org/10.1042/bst20250509
Vancouver
Price A, Lan TH, Zhou Y. Novel chemogenetic approaches in modulating calcium signaling. Biochemical Society Transactions. 2026. doi:10.1042/bst20250509
BibTeX
@article{Price2026,
author = {Price, Anna and Lan, Tien-Hung and Zhou, Yubin},
title = {Novel chemogenetic approaches in modulating calcium signaling},
journal = {Biochemical Society Transactions},
year = {2026},
doi = {10.1042/bst20250509}
}
EUVIMED